α-Synuclein seeds have been identified in various tissues in patients with synucleinopathies. We have developed real-time quaking-induced conversion combined with immunoprecipitation, a method that enables the detection of α-synuclein seeds from the serum of patients with synucleinopathies. This method can lay the foundation for the biological diagnosis of synucleinopathies.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Hawkes, C. H., Tredici, K. D. & Braak, H. Parkinson’s disease: a dual-hit hypothesis. Neuropathol. Appl. Neurobiol. 33, 599–614 (2007). An article on the ‘dual-hit’ hypothesis that the initial events of sporadic PD involve access to the brain via the stomach and nose.
Lohmann, S. et al. Oral and intravenous transmission of α-synuclein fibrils to mice. Acta. Neuropathol. 138, 515–533 (2019). This paper discusses the blood pathway of α-synuclein spread.
Chang, C. W., Yang, S. Y., Yang, C. C., Chang, C. W. & Wu, Y. R. Plasma and serum alpha-synuclein as a biomarker of diagnosis in patients with Parkinson’s disease. Front. Neurol. 10, 1388 (2019). This article discusses peripheric α-synuclein as a biomarker.
Zubelzu, M., Morera-Herreras, T., Irastorza, G., Gómez-Esteban, J. C. & Murueta-Goyena, A. Plasma and serum alpha-synuclein as a biomarker in Parkinson’s disease: A meta-analysis. Parkinsonism Relat. Disord. 99, 107–115 (2022). An article showing that increased total plasma or serum α-synuclein levels in PD primarily occur in early phases of the disease.
Fairfoul, G. et al. Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies. Ann. Clin. Transl. Neurol. 3, 812–818 (2016). An article on RT-QuIC analysis of cerebrospinal fluid for the early clinical assessment of patients with α-synucleinopathies.
Shahnawaz, M. et al. Discriminating α-synuclein strains in Parkinson’s disease and multiple system atrophy. Nature 578, 273–277 (2020). An article on the potential development of a biochemical assay to discriminate between PD and MSA.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This is a summary of: Okuzumi, A. et al. Propagative α-synuclein seeds as serum biomarkers for synucleinopathies. Nat. Med. https://doi.org/10.1038/s41591-023-02358-9 (2023).
Rights and permissions
About this article
Cite this article
Detecting α-synuclein seeds in serum to diagnose synucleinopathies. Nat Med 29, 1328–1329 (2023). https://doi.org/10.1038/s41591-023-02402-8
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-023-02402-8
